These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10408702)

  • 41. Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft.
    Kraeber-Bodéré F; Bodet-Milin C; Niaudet C; Saï-Maurel C; Moreau A; Faivre-Chauvet A; Thomare P; Deleris G; Estieu-Gionnet K; Bikfalvi A; Barbet J; Paris F
    J Nucl Med; 2010 Apr; 51(4):624-31. PubMed ID: 20351352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid.
    Cao Z; Joseph WR; Browne WL; Mountjoy KG; Palmer BD; Baguley BC; Ching LM
    Br J Cancer; 1999 May; 80(5-6):716-23. PubMed ID: 10360649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of corneal neovascularization with propolis extract.
    Keshavarz M; Mostafaie A; Mansouri K; Shakiba Y; Motlagh HR
    Arch Med Res; 2009 Jan; 40(1):59-61. PubMed ID: 19064129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of thalidomide on the expression of angiogenesis growth factors in human A549 lung adenocarcinoma cells.
    Li X; Liu X; Wang J; Wang Z; Jiang W; Reed E; Zhang Y; Liu Y; Li QQ
    Int J Mol Med; 2003 Jun; 11(6):785-90. PubMed ID: 12736723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thalidomide prevents donor corneal graft neovascularization in an alkali burn model of corneal angiogenesis.
    Abbas A; Khan B; Feroze AH; Hyman GF
    J Pak Med Assoc; 2002 Oct; 52(10):476-82. PubMed ID: 12553678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sulindac inhibits colorectal tumour growth, but not prostaglandin synthesis in the rat.
    Charalambous D; Skinner SA; O'Brien PE
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1195-200. PubMed ID: 9918425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
    Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
    Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator.
    Yin T; Wang G; Ye T; Wang Y
    Sci Rep; 2016 Jan; 6():19534. PubMed ID: 26777116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tecogalan sodium inhibits corneal neovascularization induced by basic fibroblast growth factor.
    Murata T; Ishibashi T; Yoshikawa H; Khalil A; Inomata H
    Ophthalmic Res; 1995; 27(6):330-4. PubMed ID: 8927305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of angiogenesis by THAM-derived cotelomers endowed with thalidomide moieties.
    Périno S; Contino-Pépin C; Satchi-Fainaro R; Butterfield C; Pucci B
    Bioorg Med Chem Lett; 2004 Jan; 14(2):421-5. PubMed ID: 14698173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased anti-tumour efficacy of doxorubicin when combined with sulindac in a xenograft model of an MRP-1-positive human lung cancer.
    O'Connor R; Heenan M; Connolly L; Larkin A; Clynes M
    Anticancer Res; 2004; 24(2A):457-64. PubMed ID: 15152944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors.
    Chan DC; Earle KA; Zhao TL; Helfrich B; Zeng C; Baron A; Whitehead CM; Piazza G; Pamukcu R; Thompson WJ; Alila H; Nelson P; Bunn PA
    Clin Cancer Res; 2002 Mar; 8(3):904-12. PubMed ID: 11895925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Demonstration of inhibitory effect of oral shark cartilage on basic fibroblast growth factor-induced angiogenesis in the rabbit cornea.
    González RP; Soares FS; Farias RF; Pessoa C; Leyva A; de Barros Viana GS; Moraes MO
    Biol Pharm Bull; 2001 Feb; 24(2):151-4. PubMed ID: 11217082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study.
    Piccaluga PP; Visani G; Pileri SA; Ascani S; Grafone T; Isidori A; Malagola M; Finelli C; Martinelli G; Ricci P; Baccarani M; Tura S
    Leukemia; 2002 Sep; 16(9):1609-14. PubMed ID: 12200671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor.
    Lin P; Sankar S; Shan S; Dewhirst MW; Polverini PJ; Quinn TQ; Peters KG
    Cell Growth Differ; 1998 Jan; 9(1):49-58. PubMed ID: 9438388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
    Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid.
    Browne WL; Wilson WR; Baguley BC; Ching LM
    Anticancer Res; 1998; 18(6A):4409-13. PubMed ID: 9891501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model.
    Nicastro HL; Grubbs CJ; Margaret Juliana M; Bode AM; Kim MS; Lu Y; You M; Milne GL; Boring D; Steele VE; Lubet RA
    Cancer Prev Res (Phila); 2014 Feb; 7(2):246-54. PubMed ID: 24346344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thalidomide reduces vascular density in granulation tissue of subcutaneously implanted polyvinyl alcohol sponges in guinea pigs.
    Or R; Feferman R; Shoshan S
    Exp Hematol; 1998 Mar; 26(3):217-21. PubMed ID: 9502617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.